Specialised Commissioning Alert: Return on investment tool: colorectal cancer

Frailty

Home
Frailty
MSK
COVID-19

1 November 2017

Return on investment tool: colorectal cancer

Return on investment tool: colorectal cancer
PHE 1 November 2017

A tool to help local commissioners understand the economic case for early diagnosis of bowel cancer, colon cancer and rectal cancer.

Email This BlogThis!Share to X Share to Facebook Share to Pinterest

Labels: cancer, ROI, tool

Newer Post Older Post Home

Here you will find....

published evidence to support commissioning of NHS England Specialised Services and related pathways. (Drug interventions are NOT covered.)

See the list of resources scanned for inclusion.

For evidence to support commissioning by CCGs see the CCG alert blog.

This blog is compiled by

Anne Gray, Knowledge Officer at Arden & Greater East Midlands CSU, to support Arden & GEM CSU staff and customers.

Labels

*201804 *201805 *201806 *201807 *201808 *201809 201802 201805 201808 201809 201810 201811 201812 201901 201902 201903 201904 201905 201906 201907 201908 201909 201910 201911 201912 202001 202002 202003 202005 202006 202007 202008 202010 2ww 62 day target ACO acute services adult critical care after COVID-19 aftercare alliance artificial intelligence assurance audit bed capacity benchmarking BI Blood and Infection burns CAHMS camhs cancer capitation cardiology case management case study CGA chemotherapy Children and Young Adult Cancer Services Circulatory System clinical pathways Clinical Senate collaboration colorectal services communication comorbidity complex rehabilitation congenital heart disease cost effectiveness COVID-19 CQUIN critical care CYP cystic fibrosis data decision aids decommissioning dermatology diagnosis digital technology disability ear early warning eating disorders economic analysis efficiency EOL excess treatment costs family finance follow-up Frailty gender dysphoria gene therapy genomics geographic variation GIRFT good practice guide guideline gynaecology HCTED Hepatobiliary and Pancreas Highly Specialised HIV horizon scanning HSIB ICU Identification Rules IFR Improving Value inequalities infectious diseases innovation Integrated Care Systems integration interesting reads Internal medicine legislation litigation Long Term Plan LOS machine learning maternity MDT medical devices mental health mHealth mobile technology modelling tool mortality MRI MSK multiple sclerosis Neonatal Critical Care neurosciences new care models NHS England NHS planning guidance NICE NICU Ombudsman ophthalmology organisational model out of hospital Out of Hours outcome based paediatric critical care paediatric medicine Paediatric neurosciences pain palliative care pathology patient access patient choice patient experience patient safety patient satisfaction patient travel performance personalised care personalised medicine PICU pilot place based services prediction tools Primary Care private sector procurement PSS PSSAG public engagement QALY QoL Quality Improvement quality of life quality standard radiotherapy rare diseases readmission renal research respiratory review robot ROI screening secure mental health secure settings self monitoring service delivery service evaluation service reconfiguration service specification specialised respiratory specialist centres spinal services SSCC statistics STPs straight to test surgery surgey surveillance technology telemedicine tomography tool toolkit transplantation Trauma treatment variation urology Vanguard vascular services veterans waiting lists Women and Children workforce

Popular Posts

Comprehensive Investment Appraisal Model and guidance for the NHS
Cancer treatment rates
Models of generalist and specialist care in smaller hospitals in England: a mixed-methods study.
Robotic system for joint fractures
National Audit of Breast Cancer in Older Patients: Annual Reports

Blog Archive

Total Pageviews

Awesome Inc. theme. Powered by Blogger.